Nektar Therapeutics (0UNL.L)

USD 1.01

(-1.02%)

Eps Summary of Nektar Therapeutics

  • Nektar Therapeutics's latest annual eps in 2023 was -1.45 USD , up 26.4% from previous year.
  • Nektar Therapeutics's latest quarterly eps in 2024 Q2 was -0.25 USD , down -31.58% from previous quarter.
  • Nektar Therapeutics reported an annual eps of -1.97 USD in 2022, up 31.12% from previous year.
  • Nektar Therapeutics reported an annual eps of -2.86 USD in 2021, down -14.86% from previous year.
  • Nektar Therapeutics reported a quarterly eps of -0.19 USD for 2024 Q1, up 13.64% from previous quarter.
  • Nektar Therapeutics reported a quarterly eps of N/A for 2023 FY, up 26.4% from previous quarter.

Annual Eps Chart of Nektar Therapeutics (2023 - 1994)

Historical Annual Eps of Nektar Therapeutics (2023 - 1994)

Year Eps Eps Growth
2023 -1.45 USD 26.4%
2022 -1.97 USD 31.12%
2021 -2.86 USD -14.86%
2020 -2.49 USD 1.19%
2019 -2.52 USD -166.67%
2018 3.78 USD 709.68%
2017 -0.62 USD 43.64%
2016 -1.10 USD -80.33%
2015 -0.61 USD -45.24%
2014 -0.42 USD 70.0%
2013 -1.40 USD 6.67%
2012 -1.50 USD -26.05%
2011 -1.19 USD -197.5%
2010 -0.40 USD 63.96%
2009 -1.11 USD -200.0%
2008 -0.37 USD -2.78%
2007 -0.36 USD 79.07%
2006 -1.72 USD 20.0%
2005 -2.15 USD -65.38%
2004 -1.30 USD -54.76%
2003 -0.84 USD 56.7%
2002 -1.94 USD 58.81%
2001 -4.71 USD -103.02%
2000 -2.32 USD -105.31%
1999 -1.13 USD -94.83%
1998 -0.58 USD -61.11%
1997 -0.36 USD 18.18%
1996 -0.44 USD -12.82%
1995 -0.39 USD 9.3%
1994 -0.43 USD 0.0%

Peer Eps Comparison of Nektar Therapeutics

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 28.218%
Dynavax Technologies Corporation -0.05 USD -2823.387%
Supernus Pharmaceuticals, Inc. 0.02 USD 6116.598%
Perrigo Company plc -0.09 USD -1444.196%
Illumina, Inc. -7.35 USD 80.272%
Thermo Fisher Scientific Inc. 15.53 USD 109.337%
Iovance Biotherapeutics, Inc. -1.89 USD 23.28%
Walgreens Boots Alliance, Inc. -10.01 USD 85.514%
IQVIA Holdings Inc. 7.39 USD 119.621%
Heron Therapeutics, Inc. -0.80 USD -81.25%
Regeneron Pharmaceuticals, Inc. 37.05 USD 103.914%
Unity Biotechnology, Inc. -2.70 USD 46.296%
Waters Corporation 10.87 USD 113.339%
Biogen Inc. 8.02 USD 118.08%
Sangamo Therapeutics, Inc. -1.48 USD 2.027%
Evolus, Inc. -1.08 USD -34.259%
Adicet Bio, Inc. -3.31 USD 56.193%
Cara Therapeutics, Inc. -2.19 USD 33.79%
bluebird bio, Inc. -1.93 USD 24.87%
Esperion Therapeutics, Inc. -2.03 USD 28.571%
FibroGen, Inc. -2.92 USD 50.342%
Agilent Technologies, Inc. 4.22 USD 134.36%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 85.936%
Homology Medicines, Inc. -7.41 USD 80.432%
Geron Corporation -0.32 USD -353.125%
Alnylam Pharmaceuticals, Inc. -3.52 USD 58.807%
Amicus Therapeutics, Inc. -0.51 USD -184.314%
Myriad Genetics, Inc. -1.39 USD -4.317%
Viking Therapeutics, Inc. -0.91 USD -59.341%
Intellia Therapeutics, Inc. -5.42 USD 73.247%
Zoetis Inc. 5.08 USD 128.543%
Abeona Therapeutics Inc. -2.53 USD 42.688%
Mettler-Toledo International Inc. 36.10 USD 104.017%
BioMarin Pharmaceutical Inc. 0.89 USD 262.921%
Vertex Pharmaceuticals Incorporated 14.05 USD 110.32%
Kala Pharmaceuticals, Inc. -17.35 USD 91.643%
Ionis Pharmaceuticals, Inc. -2.56 USD 43.359%
Atara Biotherapeutics, Inc. -65.18 USD 97.775%
Verastem, Inc. -3.96 USD 63.384%
Axsome Therapeutics, Inc. -5.27 USD 72.486%
Aclaris Therapeutics, Inc. -1.27 USD -14.173%
Sarepta Therapeutics, Inc. -5.80 USD 75.0%
OPKO Health, Inc. -0.25 USD -480.0%
Exelixis, Inc. 0.65 USD 323.077%
Neurocrine Biosciences, Inc. 2.56 USD 156.641%
Corcept Therapeutics Incorporated 1.02 USD 242.157%
Anavex Life Sciences Corp. -0.60 USD -141.667%
uniQure N.V. -6.47 USD 77.589%
Imunon, Inc. -2.16 USD 32.87%
Blueprint Medicines Corporation -8.37 USD 82.676%
Insmed Incorporated -5.34 USD 72.846%
Halozyme Therapeutics, Inc. 2.13 USD 168.075%
Agios Pharmaceuticals, Inc. -6.33 USD 77.093%
TG Therapeutics, Inc. 0.09 USD 1723.74%
Incyte Corporation 2.67 USD 154.307%
Emergent BioSolutions Inc. -14.85 USD 90.236%